Wellington Management Group’s Fulcrum Therapeutics FULC Stock Holding History

Wellington Management Group’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	285,084 +166,484	+140%	+$1.01M	﹤0.01%	1743
2026 Q1	$910K	Sell	118,600 -27,827	-19%	-$258K	﹤0.01%	1690
2025 Q4	$1.66M	Sell	146,427 -32,931	-18%	-$335K	﹤0.01%	1636
2025 Q3	$1.65M	Buy	179,358 +52,956	+42%	+$383K	﹤0.01%	1682
2025 Q2	$870K	Buy	+126,402	New	+$676K	﹤0.01%	1738
2025 Q1	–	Sell	-172,158	Closed	-$809K	–	1985
2024 Q4	$809K	Sell	172,158 -4,003	-2%	-$14.8K	﹤0.01%	1756
2024 Q3	$629K	Sell	176,161 -6,568	-4%	-$48.7K	﹤0.01%	1788
2024 Q2	$1.13M	Buy	182,729 +10,069	+6%	+$76.3K	﹤0.01%	1648
2024 Q1	$1.63M	Buy	+172,660	New	+$1.54M	﹤0.01%	1571

Other funds holding FULC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group's FULC Position: Q2 2026 in Review

Wellington Management Group increased its Fulcrum Therapeutics (FULC) stake by 140% in Q2 2026, buying an estimated $1.01M and bringing the position to 285,084 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

Wellington Management Group first reported a position in FULC in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.66M in Q4 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

Wellington Management Group held 285,084 shares of Fulcrum Therapeutics worth $1.04M as of Q2 2026.
Wellington Management Group bought 166,484 Fulcrum Therapeutics shares in Q2 2026, an estimated $1.01M.
Fulcrum Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1743 holding.
Wellington Management Group first reported a position in Fulcrum Therapeutics in Q1 2024 and has held it in 9 quarters since.
Wellington Management Group's Fulcrum Therapeutics position peaked at $1.66M in Q4 2025.
155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.